Wearable Dark-adaptometer in Normal Adult Healthy Volunteers

Sponsor
University of Liverpool (Other)
Overall Status
Unknown status
CT.gov ID
NCT02674425
Collaborator
(none)
20
1

Study Details

Study Description

Brief Summary

Conventional dark-adaptometers are unsuitable as a mass screening tool due to their high cost, lack of easy portability, need of trained staff and a totally dark room to be operated, arbitrary testing procedures, associated time waste in clinic and patient burden to mention a few. Consequently, dark adaptometers are not routinely used as clinical tools for retinal diagnosis and monitoring despite the inherent benefits over other visual electrophysiology equipment such as the ERG system, whose cost and features may often be surplus to optometrists' requirements.

This trial will assess the dark-adaptometry testing performance of a novel light-emitting system by generating full dark-adaptation threshold functions in normal adult healthy volunteers.

The novel system has been proposed to overcome the issues associated with current instrumentation; it is semi-automatic and easy to use without the need of any skilled operator.

It is envisaged that this system could spread the practice of dark-adaptometry testing and its adoption by high-street optometrists. This will allow diagnosing a number of retinal pathologies more quickly and more reliably that, faced with an ageing population, represents a major asset to the Health Community and the NHS.

This trial will involve 20 healthy volunteers, distributed in equal number in 2 groups of 18-40 and 50-70 years old, respectively. Proven the good health and eye condition of the participants, one of their eyes will be randomly-allocated and undergo dark-adaptometry testing 3 times on separate days within 3 weeks.

Testing will clarify whether by using the novel system it is possible to reproduce state-of-the-art threshold measurements as good or better than those produced by commercially-available dark-adaptometers. Threshold measurements in the elderly will be compared with literature data adjusted to exclude aged crystalline lens and pupillary miosis contributions. Data variability and system usability will be also assessed.

Condition or Disease Intervention/Treatment Phase
  • Device: Dark Adaptometer

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Case-Only
Official Title:
Evaluation of a Novel Wearable Light-emitting System for Measuring Dark-adaptation Thresholds in Normal Adult Healthy Volunteers
Study Start Date :
Sep 1, 2016
Anticipated Primary Completion Date :
May 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Young adults (18-40)

Healthy adult volunteers, aged between 18 and 40, with no prior/current eye problems or family history of genetic eye diseases and good general health.

Device: Dark Adaptometer

Older adults (50-70)

Healthy adult volunteers, aged between 50 and 70, with no prior/current eye problems or family history of genetic eye diseases and good general health.

Device: Dark Adaptometer

Outcome Measures

Primary Outcome Measures

  1. Rod-cone break measurement [April 2016 - up to 3 weeks]

  2. Absolute threshold measurement [April 2016 - up to 3 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Refractive error: ≤ ±5 dioptres spherical (myopia/hyperopia) equivalent; ≤ 3 dioptres cylinder (astigmatism) equivalent.
Exclusion Criteria:
  • Subjects not in age range and/or unable to fully understand the informed consent and/or unable to comply with study procedures.

  • Self-reported history of depression, lack of sleep, psychiatric disorders, or neurological diseases such as Alzheimer's and Parkinson's disease.

  • Self-reported history of diabetes, stroke, or multiple sclerosis.

  • Self-reported hypovitaminosis A, alcoholism, liver or intestinal disease, malabsorption, protein calorie malnutrition, or sickle cell anaemia.

  • Use of psychoactive drugs (including lithium salts for mood stabilisation).

  • Use of dietary intake of ascorbic acid, vitamin A, B, E or other antioxidant supplements in the last two weeks.

  • Recurrent practice of activities that expose the retina to ultra-violet radiation such as sailing, fishing, sunbathing or tanning saloons.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Liverpool Liverpool Merseyside United Kingdom L78TX

Sponsors and Collaborators

  • University of Liverpool

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alessandro Giuliano, KTP Associate, University of Liverpool
ClinicalTrials.gov Identifier:
NCT02674425
Other Study ID Numbers:
  • UoL001185
First Posted:
Feb 4, 2016
Last Update Posted:
Oct 25, 2016
Last Verified:
Oct 1, 2016
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 25, 2016